Sameer G Jhavar1, Rajiv Sarin2, Supriya Chopra1, Ashwin Kotnis3, Rita Mulherkar3, Roger A’Hern4, Jai Prakash Agarwal1, Shyam Kishore Shrivastava1, Ketayun A Dinshaw1
1Department of Radiation Oncology, Tata Memorial Centre, Mumbai, India
2Department of Radiation Oncology and Cancer genetics Unit, Tata Memorial Centre, Mumbai, India
3Section of Genetic Engineering, Tata Memorial Centre, Mumbai, India
4Royal Marsden Hospital NHS Trust, London, United Kingdom
DOI: 10.1186/1477-3163-4-6
ABSTRACT
Upper Aero digestive Tract (UADT) is the commonest site for the development of second cancer in females after primary cervical cancer. Glutathione S-transferase ( GSTM1 and / or T1 ) null genotype modulates the risk of developing UADT cancer (primary as well as second cancer). The aim of this study was to evaluate the difference in GST null genotype frequencies in females with paired cancers in the UADT and genital region as compared to females with paired cancers in the UADT and non-genital region. Forty-nine females with a cancer in the UADT and another cancer (at all sites-genital and non-genital) were identified from a database of patients with multiple primary neoplasms and were analyzed for the GSTM1 and T1 genotype in addition to known factors such as age, tobacco habits, alcohol habits and family history of cancer. Frequencies of GSTM1 null, GSTT1 null, and either GSTM1/T1 null were higher in females with paired occurrence of cancer in the UADT and genital site (54%, 33% and 75% respectively) in comparison to females with paired occurrence of cancer in the UADT and non-genital sites (22%, 6% and 24% respectively). The significantly higher inherited frequency of either GSTM1 / T1 null genotype in females with a paired occurrence of cancers in UADT and genital region (p = 0.01), suggests that these females are more susceptible to damage by carcinogens as compared to females who have UADT cancers in association with cancers at non-genital sites.